自和新陈代谢之间的交叉:急性髓性白血病中细胞存活的影响
Yongfeng Chen1, Jia Chen2, Zhenyou Zou3
1Department of Basic Medical Sciences, Medical College of Taizhou University, 318000, Taizhou, Zhejiang, China. cyfeng@tzc.edu.cn.
Cell death discovery
|January 24, 2024
概括
自和细胞代谢是急性髓性白血病 (AML) 生存和化疗耐药性的关键. 了解它们的相互作用可能会揭示新的AML治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 急性髓性白血病 (AML) 由于化疗反应较低和复发率高,因此存在挑战.
- 在AML中,化疗耐药性是有效治疗的重要障碍.
- 瘤细胞代谢和自越来越多地与AML的进展和存活有关.
研究的目的:
- 审查了解AML细胞中自和新陈代谢之间的相互作用的最新进展.
- 突出这一相互作用在AML细胞存活率和耐药性的作用.
- 探索针对这种途径的潜在治疗策略.
主要方法:
- 关于AML中自和代谢的最近研究的文献综述.
- 分析自细胞在化疗期间支持AML细胞存活的机制.
- 调查AML细胞代谢如何影响自活动.
主要成果:
- 自能通过在化疗期间提供能量和必需成分来维持AML细胞.
- AML细胞的代谢状态会影响自,从而形成一个反循环.
- 自和新陈代谢的协调作用有助于化学疗法耐药性.
结论:
- 自和新陈代谢之间的相互作用对AML细胞存活和抵抗至关重要.
- 针对这种相互作用可以为AML提供新的治疗方法.
- 进一步了解可能会导致对耐药性或复发性AML的改善治疗策略.
相关概念视频
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Delivery Pathways to the Lysosome
6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


